116 Oncogenic reprogramming of human primary melanocytes into potent tumor initiating cells
Publication
, Conference
Li, F; Liu, X; Li, C
Published in: Journal of Investigative Dermatology
May 2017
Duke Scholars
Published In
Journal of Investigative Dermatology
DOI
ISSN
0022-202X
Publication Date
May 2017
Volume
137
Issue
5
Start / End Page
S20 / S20
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, F., Liu, X., & Li, C. (2017). 116 Oncogenic reprogramming of human primary melanocytes into potent tumor initiating cells. In Journal of Investigative Dermatology (Vol. 137, pp. S20–S20). Elsevier BV. https://doi.org/10.1016/j.jid.2017.02.130
Li, F., X. Liu, and C. Li. “116 Oncogenic reprogramming of human primary melanocytes into potent tumor initiating cells.” In Journal of Investigative Dermatology, 137:S20–S20. Elsevier BV, 2017. https://doi.org/10.1016/j.jid.2017.02.130.
Li F, Liu X, Li C. 116 Oncogenic reprogramming of human primary melanocytes into potent tumor initiating cells. In: Journal of Investigative Dermatology. Elsevier BV; 2017. p. S20–S20.
Li, F., et al. “116 Oncogenic reprogramming of human primary melanocytes into potent tumor initiating cells.” Journal of Investigative Dermatology, vol. 137, no. 5, Elsevier BV, 2017, pp. S20–S20. Crossref, doi:10.1016/j.jid.2017.02.130.
Li F, Liu X, Li C. 116 Oncogenic reprogramming of human primary melanocytes into potent tumor initiating cells. Journal of Investigative Dermatology. Elsevier BV; 2017. p. S20–S20.
Published In
Journal of Investigative Dermatology
DOI
ISSN
0022-202X
Publication Date
May 2017
Volume
137
Issue
5
Start / End Page
S20 / S20
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences